Denver Investment Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-10,678
| Closed | -$139K | – | 484 |
|
|
2016
Q2 | $139K | Sell |
10,678
-2,240
| -17% | -$29.2K | 0.01% | 422 |
|
|
2016
Q1 | $142K | Sell |
12,918
-14,396
| -53% | -$158K | 0.01% | 416 |
|
|
2015
Q4 | $251K | Sell |
27,314
-3,102
| -10% | -$28.5K | 0.01% | 413 |
|
|
2015
Q3 | $211K | Sell |
30,416
-1,047
| -3% | -$7.26K | 0.01% | 456 |
|
|
2015
Q2 | $309K | Sell |
31,463
-8,592
| -21% | -$84.4K | 0.01% | 419 |
|
|
2015
Q1 | $355K | Buy |
40,055
+11,666
| +41% | +$103K | 0.01% | 444 |
|
|
2014
Q4 | $249K | Sell |
28,389
-12,910
| -31% | -$113K | 0.01% | 512 |
|
|
2014
Q3 | $285K | Sell |
41,299
-4,473
| -10% | -$30.9K | 0.01% | 445 |
|
|
2014
Q2 | $241K | Sell |
45,772
-16,941
| -27% | -$89.2K | 0.01% | 501 |
|
|
2014
Q1 | $285K | Buy |
62,713
+43,971
| +235% | +$200K | 0.01% | 477 |
|
|
2013
Q4 | $94 | Hold |
18,742
| – | – | ﹤0.01% | 554 |
|
|
2013
Q3 | $95K | Buy |
18,742
+4,115
| +28% | +$20.9K | ﹤0.01% | 562 |
|
|
2013
Q2 | $73K | Buy |
+14,627
| New | +$73K | ﹤0.01% | 538 |
|